MedTrace Logo

Silkworm Pupa Powder Improves Alzheimer's Disease

NCT07638449 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-06-10

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if silkworm pupa powder works to treat Alzheimer's disease in patients. It will also learn about the safety of silkworm pupa powder, and its effect on patients' nutritional and frailty status. The main questions it aims to answer are:

* Does silkworm pupa powder improve cognitive function and daily living abilities?
* Does silkworm pupa powder improve nutritional status and frailty?
* What medical problems do participants have when taking silkworm pupa powder?

Researchers will evaluate the treatment by comparing the participants' conditions after taking the powder to their baseline conditions (a single-arm study without a placebo) to see if silkworm pupa powder works to treat Alzheimer's disease.

Participants will:

* Take silkworm pupa powder every day for 12 weeks
* Visit the clinic once every 4 weeks for checkups and tests
* Use an electronic punch-card system daily and report any symptoms

Conditions

Interventions

DIETARY_SUPPLEMENT

Silkworm pupa powder

Silkworm pupa powder, 2 times a day, two packets (12\*2 g) each time, take with warm water, before meals, for three months

Sponsors & Collaborators

  • Zhejiang Provincial Tongde Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07638449 on ClinicalTrials.gov